Tlie Senior Leaders are responsible for tlie overall planning and operations of the programs and activities of the Vanderbilt-lngram Cancer Center (VICC). The Senior Leadership is comprised of the Director, Deputy Director and nine Associate Directors and has undergone transition during the current project period. As part of a planned succession following the successful 2003 competing renewal, Harold Moses, M.D., stepped down and Raymond DuBois, M.D., was named Director in in January 2005. Two years later he he left to become Provost and Executive Vice President of Academic Affairs at M.D. Anderson Cancer Center. Jennifer Pietenpol, Ph.D., then Associate Director for Basic Research, was asked to serve as interim director during a national search. In January 2008, she was selected as Director based on scientific accomplishments, leadership skills and administrative experience. Scott Hiebert, Ph.D., previously leader of the Signal Transduction and Cell Proliferation Research Program, was named Associate Director for Basic Science Research Programs in 2008 overseeing the basic science research programs and implementing the strategic plan for these programs. Also in 2008, William Blot, Ph.D., was named Associate Director for Cancer Prevention, Control and Population-Based Research. He provides senior leadership to the two coleaders of the Cancer Epidemiology, Prevention and Control Research Program. Four additional Associate Director positions have been added. Dr. Elizabeth Williams was recruited in 2005 as Associate Director for Minority Affairs with primary responsibility for health promotion, education, access to care, clinical trials and behavioral interventions for minority populations. Bettina Beech, Dr.P.H., was named in 2006 as Associate Director for Health Disparities Research, responsible for the promotion of health disparities research. In 2008, Beth Price, M.B.A., was named Associate Director for Administration and CEO and in 2009, Dr. Yu Shyr was named Associate Director for Quantitative Sciences Integration with oversight for integrating quantitative science throughout the center and facilitating VICC member access to complex genomic tools and analysis of high-dimensional data sets. Senior Leadership otherwise remains unchanged with David Johnson, M.D., as Deputy Director; Daniel Beauchamp, M.D., as Associate Director for Clinical Research Programs; Mark Magnuson, Ph.D., as Associate Director for Shared Resources; Ann Richmond, Ph.D., as Associate Director for Research Education; and Ms. Susan Mills as Associate Director for CCSG Administration.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA068485-16
Application #
8379901
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2012-09-01
Budget End
2013-08-31
Support Year
16
Fiscal Year
2012
Total Cost
$2,352,617
Indirect Cost
$2,117,500
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Saito-Diaz, Kenyi; Benchabane, Hassina; Tiwari, Ajit et al. (2018) APC Inhibits Ligand-Independent Wnt Signaling by the Clathrin Endocytic Pathway. Dev Cell 44:566-581.e8
Cardin, Dana B; Thota, Ramya; Goff, Laura W et al. (2018) A Phase II Study of Ganetespib as Second-line or Third-line Therapy for Metastatic Pancreatic Cancer. Am J Clin Oncol 41:772-776
Bloodworth, Melissa H; Rusznak, Mark; Pfister, Connor C et al. (2018) Glucagon-like peptide 1 receptor signaling attenuates respiratory syncytial virus-induced type 2 responses and immunopathology. J Allergy Clin Immunol 142:683-687.e12
Dutter, Brendan F; Ender, Anna; Sulikowski, Gary A et al. (2018) Rhodol-based thallium sensors for cellular imaging of potassium channel activity. Org Biomol Chem 16:5575-5579
Hormuth 2nd, David A; Weis, Jared A; Barnes, Stephanie L et al. (2018) Biophysical Modeling of In Vivo Glioma Response After Whole-Brain Radiation Therapy in a Murine Model of Brain Cancer. Int J Radiat Oncol Biol Phys 100:1270-1279
Rojas, Juan D; Lin, Fanglue; Chiang, Yun-Chen et al. (2018) Ultrasound Molecular Imaging of VEGFR-2 in Clear-Cell Renal Cell Carcinoma Tracks Disease Response to Antiangiogenic and Notch-Inhibition Therapy. Theranostics 8:141-155
Lewis Jr, James S; Shelton, Jeremy; Kuhs, Krystle Lang et al. (2018) p16 Immunohistochemistry in Oropharyngeal Squamous Cell Carcinoma Using the E6H4 Antibody Clone: A Technical Method Study for Optimal Dilution. Head Neck Pathol 12:440-447
Vierra, Nicholas C; Dickerson, Matthew T; Jordan, Kelli L et al. (2018) TALK-1 reduces delta-cell endoplasmic reticulum and cytoplasmic calcium levels limiting somatostatin secretion. Mol Metab 9:84-97
Schlegel, Cameron; Weis, Victoria G; Knowles, Byron C et al. (2018) Apical Membrane Alterations in Non-intestinal Organs in Microvillus Inclusion Disease. Dig Dis Sci 63:356-365
Piñeros, Marion; Frech, Silvina; Frazier, Lindsay et al. (2018) Advancing Reliable Data for Cancer Control in the Central America Four Region. J Glob Oncol :1-11

Showing the most recent 10 out of 2462 publications